查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1607171

基因組市場：按技術、產品、應用和最終用戶分類 - 全球預測 2025-2030

Gene Panel Market by Technique (Microarray, Next-Generation Sequencing, Polymerase Chain Reaction), Product (Test Kits, Testing Services), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年基因面板市值為31.1億美元，預計2024年將達到34.1億美元，複合年成長率為9.99%，到2030年將達到60.6億美元。

基因組是使用次世代定序儀技術同時測試的基因的集合。這對於識別與各種疾病相關的基因突變以及準確和個人化的醫療至關重要。對基因組的需求源於其提供快速、全面的遺傳洞察並提高診斷準確性和治療個性化的能力。其應用涵蓋多個領域，包括腫瘤學以促進突變檢測以進行標靶治療和遺傳疾病以進行早期診斷。在最終使用場景中，基因組在臨床診斷、研究機構和醫院中至關重要，尤其是在腫瘤學和罕見疾病領域。

主要市場統計
基準年[2023] 31.1億美元
預測年份 [2024] 34.1億美元
預測年份 [2030] 60.6億美元
複合年成長率（%） 9.99%

市場成長受到個人化醫療需求不斷成長、定序技術進步和研究經費增加的影響。遺傳疾病和癌症的日益普及增加了對基因組等有效診斷工具的需求。最新的機會在於開發檢測更廣泛基因並提高準確性和速度的面板。隨著人們對個人基因組學認知的提高，對直接面對消費者的基因檢測的興趣激增。對公司的建議包括投資擴大基因組的範圍以涵蓋更多罕見疾病，並與醫療保健提供者合作將測試納入日常實踐。

然而，測試成本上升、資料解釋複雜和監管環境等挑戰正在阻礙市場成長。遺傳資料的複雜性需要熟練的人員，而不同地區監管標準的差異可能會阻礙全球市場的擴張。業務成長的創新領域包括開發具有成本效益的綜合面板以及在資料分析中採用人工智慧來簡化解釋過程。公司可以專注於創建不僅針對引起疾病的突變，還針對藥物基因組學的面板，以實現更好的藥物反應，從而強化個人化醫療趨勢。此外，擴大與生物技術公司和學術研究機構的夥伴關係可以有效推動進步和市場擴張。您還可以透過主動回應並領先於監管變化來提高競爭力。

市場動態：揭示快速發展的基因面板市場的關鍵市場洞察

供需的動態交互作用正在改變基因組市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 遺傳疾病和罕見疾病迅速增加
    • 對個人化藥物的需求不斷成長
    • 多基因面板測試在癌症治療中的快速普及
  • 市場限制因素
    • 確保遺傳資料安全的問題
  • 市場機會
    • 政府對群體定序的積極態度
    • 介紹基於次世代定序的臨床研究的新基因panel
  • 市場挑戰
    • 診斷測試的準確性問題和標準化問題

波特五力：駕馭基因面板市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解基因面板市場的外部影響

外部宏觀環境因素對基因面板市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解基因面板市場的競爭狀況

對基因面板市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣基因面板市場廠商績效評估

FPNV定位矩陣是評估基因面板市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，繪製基因面板市場的成功之路

基因面板市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 遺傳疾病和罕見疾病迅速增加
      • 對個人化藥物的需求不斷成長
      • 多基因面板測試在腫瘤學實踐中的快速採用
    • 抑制因素
      • 確保遺傳資料安全的相關問題
    • 機會
      • 政府首選的團體定序方法
      • 介紹基於次世代定序的用於臨床研究的新基因組
    • 任務
      • 診斷測試的準確性問題和標準化問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章基因面板市場：依技術分類

  • 微陣列
  • 次世代定序
  • 聚合酵素鏈鎖反應

第7章 基因組市場：依產品

  • 檢測套組
  • 測試服務

第8章基因面板市場：依應用分類

  • 癌症診斷
  • 遺傳疾病
  • 感染疾病
  • 藥物基因組學

第9章 基因組市場：依最終使用者分類

  • 學術研究所
  • 醫院和診斷實驗室
  • 製藥和生物技術公司

第10章 美洲基因組市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太基因體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲基因組市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Arizona Oncology
  • ARUP Laboratories
  • Becton, Dickinson, and Company
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Blueprint Genetics Oy by Quest Diagnostics
  • CENTOGENE NV
  • Cepheid by Danaher Corporation
  • Eurofins Genomics LLC
  • Everything Genetic Ltd.
  • Fulgent Genetics
  • Genewiz by Azenta Life Sciences
  • Guardant Health, Inc.
  • Illumina Inc.
  • myGenomics
  • Myriad Genetic Laboratories Inc.
  • NanoString Technologies, Inc.
  • Natera, Inc.
  • Novogene Co, Ltd.
  • PrimBio Research Institute
  • Qiagen NV
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience
Product Code: MRR-FF012EDC38AC

The Gene Panel Market was valued at USD 3.11 billion in 2023, expected to reach USD 3.41 billion in 2024, and is projected to grow at a CAGR of 9.99%, to USD 6.06 billion by 2030.

Gene panels are collections of genes examined simultaneously using next-generation sequencing technologies. They are crucial for identifying genetic mutations linked to various diseases, enabling precise and personalized medicine. The necessity of gene panels arises from their capacity to offer rapid, comprehensive genetic insights, improving diagnostic accuracy and treatment personalization. Applications span multiple domains, including oncology, where they facilitate mutation detection for targeted therapies, and genetic disorders for early diagnosis. In end-use scenarios, gene panels are vital in clinical diagnostics, research institutions, and hospitals, particularly within oncology and rare disease sectors.

KEY MARKET STATISTICS
Base Year [2023] USD 3.11 billion
Estimated Year [2024] USD 3.41 billion
Forecast Year [2030] USD 6.06 billion
CAGR (%) 9.99%

Market growth is influenced by rising demand for personalized medicine, advancements in sequencing technologies, and increasing research funding. The growing incidence of genetic disorders and cancer augments demand for effective diagnostic tools like gene panels. The latest opportunities lie in developments of panels for more extensive gene detection and enhancements in accuracy and speed. There is a burgeoning interest in direct-to-consumer genetic testing as awareness of personal genomics rises. Recommendations for businesses include investing in expanding the scope of gene panels to encompass more rare diseases and collaborating with healthcare providers to integrate testing into regular practice.

However, challenges such as high costs of testing, complex data interpretation, and regulatory landscapes hamper market growth. The intricate nature of genetic data necessitates skilled personnel, and the variability in regulatory standards across regions can impede global market expansion. Innovative areas for business growth include developing cost-effective, comprehensive panels and employing artificial intelligence for data analysis to streamline interpretation processes. Companies can focus on creating panels that target not only disease-causing mutations but also pharmacogenomics for better drug responses, reinforcing the trend towards personalized medicine. Moreover, expanding partnerships with biotech firms and academic research institutions could propel advancements and market expansion effectively. Adapting to and anticipating regulatory changes proactively can also provide a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Panel Market

The Gene Panel Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Surging prevalence of genetic disorders and rare disease
    • Growing need for the personalized medicines
    • Rapid adoption of multi-gene panel testing in oncology practice
  • Market Restraints
    • Issues in ensuring the security of genetic data
  • Market Opportunities
    • Favorable government initiatives for population sequencing
    • Introduction of new gene panels based on next-generation sequencing for clinical research
  • Market Challenges
    • Accuracy concerns and standardization issues in diagnostic testing

Porter's Five Forces: A Strategic Tool for Navigating the Gene Panel Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Panel Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Panel Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Panel Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Panel Market

A detailed market share analysis in the Gene Panel Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Panel Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Panel Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Panel Market

A strategic analysis of the Gene Panel Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Panel Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Arizona Oncology, ARUP Laboratories, Becton, Dickinson, and Company, BGI Group, Bio-Rad Laboratories, Inc., Blueprint Genetics Oy by Quest Diagnostics, CENTOGENE N.V., Cepheid by Danaher Corporation, Eurofins Genomics LLC, Everything Genetic Ltd., Fulgent Genetics, Genewiz by Azenta Life Sciences, Guardant Health, Inc., Illumina Inc., myGenomics, Myriad Genetic Laboratories Inc., NanoString Technologies, Inc., Natera, Inc., Novogene Co, Ltd., PrimBio Research Institute, Qiagen N.V., Thermo Fisher Scientific Inc., and Twist Bioscience.

Market Segmentation & Coverage

This research report categorizes the Gene Panel Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technique, market is studied across Microarray, Next-Generation Sequencing, and Polymerase Chain Reaction.
  • Based on Product, market is studied across Test Kits and Testing Services.
  • Based on Application, market is studied across Cancer Diagnostics, Genetic Disorders, Infectious Diseases, and Pharmacogenomics.
  • Based on End-User, market is studied across Academic & Research Institutes, Hospital & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surging prevalence of genetic disorders and rare disease
      • 5.1.1.2. Growing need for the personalized medicines
      • 5.1.1.3. Rapid adoption of multi-gene panel testing in oncology practice
    • 5.1.2. Restraints
      • 5.1.2.1. Issues in ensuring the security of genetic data
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable government initiatives for population sequencing
      • 5.1.3.2. Introduction of new gene panels based on next-generation sequencing for clinical research
    • 5.1.4. Challenges
      • 5.1.4.1. Accuracy concerns and standardization issues in diagnostic testing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gene Panel Market, by Technique

  • 6.1. Introduction
  • 6.2. Microarray
  • 6.3. Next-Generation Sequencing
  • 6.4. Polymerase Chain Reaction

7. Gene Panel Market, by Product

  • 7.1. Introduction
  • 7.2. Test Kits
  • 7.3. Testing Services

8. Gene Panel Market, by Application

  • 8.1. Introduction
  • 8.2. Cancer Diagnostics
  • 8.3. Genetic Disorders
  • 8.4. Infectious Diseases
  • 8.5. Pharmacogenomics

9. Gene Panel Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospital & Diagnostic Laboratories
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Gene Panel Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Gene Panel Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Gene Panel Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Arizona Oncology
  • 3. ARUP Laboratories
  • 4. Becton, Dickinson, and Company
  • 5. BGI Group
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Blueprint Genetics Oy by Quest Diagnostics
  • 8. CENTOGENE N.V.
  • 9. Cepheid by Danaher Corporation
  • 10. Eurofins Genomics LLC
  • 11. Everything Genetic Ltd.
  • 12. Fulgent Genetics
  • 13. Genewiz by Azenta Life Sciences
  • 14. Guardant Health, Inc.
  • 15. Illumina Inc.
  • 16. myGenomics
  • 17. Myriad Genetic Laboratories Inc.
  • 18. NanoString Technologies, Inc.
  • 19. Natera, Inc.
  • 20. Novogene Co, Ltd.
  • 21. PrimBio Research Institute
  • 22. Qiagen N.V.
  • 23. Thermo Fisher Scientific Inc.
  • 24. Twist Bioscience

LIST OF FIGURES

  • FIGURE 1. GENE PANEL MARKET RESEARCH PROCESS
  • FIGURE 2. GENE PANEL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENE PANEL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENE PANEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENE PANEL MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENE PANEL MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENE PANEL MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENE PANEL MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENE PANEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENE PANEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENE PANEL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GENE PANEL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES GENE PANEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES GENE PANEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. GENE PANEL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. GENE PANEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENE PANEL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENE PANEL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENE PANEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENE PANEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENE PANEL MARKET DYNAMICS
  • TABLE 7. GLOBAL GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENE PANEL MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENE PANEL MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENE PANEL MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENE PANEL MARKET SIZE, BY TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENE PANEL MARKET SIZE, BY TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENE PANEL MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENE PANEL MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENE PANEL MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENE PANEL MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENE PANEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENE PANEL MARKET SIZE, BY HOSPITAL & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENE PANEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS GENE PANEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES GENE PANEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. GENE PANEL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. GENE PANEL MARKET, FPNV POSITIONING MATRIX, 2023